 |
|||||||||||||||||||||||||
   |
Coverage of 2006 International
|
||||||||||||||||||||||||
| One Entry Inhibitor, One Question Answered |
|
| Saving the Best for Last? |
|
| Going It Alone with Monotherapy? |
|
| Kaletra vs Sustiva vs a Combination of the Two |
|
| The KLEAN Study, ACTG 5095 |
|
| Looking to the Elite |
|
| Expanded Access Program Announced for MK-0518, the First Integrase Inhibitor |
|
| More Good News of the First Integrase Inhibitor |
|
| Mixed Results for Next Generation NNRTI, Etravirine |
|
| Interactions Between HIV and the Immune System |
|
| First Day Dominated by the Two “Bills”: Clinton and Gates |
© 2008 Project Inform 1375 Mission
Street, San Francisco, CA 94103 415-558-8669
National HIV/AIDS Treatment Hotline 1-800-822-7422 (415-558-9051 local/int'l) 10a-4p Mon-Fri PST